Health Catalyst, Inc. (HCAT) - Forward P/S Multiple

Symbol and logo of brand Health Catalyst, Inc (HCAT)

Health Catalyst, Inc. (HCAT) is implementing autonomous AI systems to synchronize electronic patient records. The company's technologies aggregate data from multiple clinics, reducing costs and mortality rates. The strategy relies on the expansion of platforms into US hospital networks. This chart on GURU.Markets shows that the forward revenue multiple demonstrates a balance of value, while the 0.40 level captures the current state of the metric.

Health Catalyst Inc. - HCAT Forward P/S Multiple (period 07/04/2022 - 11/13/2026)

Metric breakdowns and analytics for Health Catalyst Inc (HCAT)

- stock price and consensus target price:
Summary company analytics:Health Catalyst (HCAT)
Product sample of Health Catalyst, Inc.

High switching barriers, driven by the integration of Health Catalyst, Inc. (HCAT) systems into clinic IT infrastructure and HIPAA compliance, ensure the stability of future cash flows. This forward price-to-sales ratio provides a real-time assessment of the asset's current value relative to expected revenues, allowing investors to determine whether the business's premium valuation is justified or if the asset is overbought ahead of a potential correction.

Competitor analysis

Veeva - Forward Price-to-Revenue Multiple|Forward Price to Sales DOCS|HealthEquity Corp - Forward P/S Multiple|Waystar Corp (WAY) - Forward Price-to-Revenue Multiple|CRVL: Forward P/S Multiple|priviahealth.com (PRVA) - Forward P/S Multiple|Forward Price-to-Revenue Multiple HURN|CERT (Certara Inc) - Price to Expected Revenue Ratio|Forward P/S Multiple OMCL|Forward P/S Multiple GoodRx Gold (GDRX)|Price-to-Projected Revenue Ratio Schrodinger, Inc. SDGR|phreesia.com - Price-to-Projected Revenue Ratio|OMDA: Forward Price-to-Revenue Multiple|Market Cap to Future Revenue Ratio Evolent Health Inc|HealthStream Corp (HSTM) - Price-to-Projected Revenue Ratio|DH - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple CCSI|AGL (agilonhealth.com) - Price to Expected Revenue Ratio|Forward Price-to-Revenue Multiple ABSI (Absci Corporation)|SY (So-Young International Inc) - Forward Price to Sales|Forward P/S Multiple NRC (National Research Corporation)|Market Cap to Expected Sales Ratio USA Mobility (SPOK)|OPRX - Price-to-Projected Revenue Ratio|TBRG (trubridge.com) - Market Cap to Projected Revenue|SLP: Forward P/S Multiple|Forward Price-to-Revenue Multiple SOPHiA GENETICS|Forward Price-to-Revenue Multiple CCLD|Research Solutions Inc. (RSSS) - Market Cap to Expected Sales Ratio|Forward P/S Multiple DLHC|ONMD (onemednet.com) - Forward Price to Sales|Forward P/S Multiple SCNX (Scienture)|HCTI - Forward Price-to-Revenue Multiple|iSpecimen Corp - Forward P/S Multiple|BFRG - Forward P/S Multiple|WORX (SCWorx Corp.) - Forward Price-to-Revenue Multiple|MSPR: Price to Expected Revenue Ratio|ICCT (iCoreConnect, Inc.) - Forward P/S Multiple|TRxADE HEALTH Inc (MEDS) - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple ORGS (Orgenesis Corp)|Price to Expected Revenue Ratio RCM|Sharecare, Inc. - Forward Price-to-Revenue Multiple|Forward Price to Sales STRM|SYRA - Price-to-Projected Revenue Ratio|Apollo Medical Holdings (AMEH) - Forward Price-to-Revenue Multiple|MODN: Forward P/S Multiple|Market Cap to Future Revenue Ratio NextGen Healthcare Corp (NXGN)